Alimentiv Inc. launches Alimentiv Statistics

London, Ontario, Canada, June 27, 2023, Alimentiv Inc. (“Alimentiv”) today announced the launch of Alimentiv Statistics, a core Alimentiv product line focused on being the recognized leader for statistical advisory and analysis services in clinical research through a Statistics Centre of Excellence (SCoE) and a robust statistical and analytical workforce.

In March 2021, Alimentiv Health Trust acquired McDougall Scientific Ltd., a Toronto-based niche Contract Research Organization providing data services for over 37 years, supporting drug and medical device clinical research in a broad spectrum of therapeutic areas. The acquisition strengthens Alimentiv’s statistical expertise in studies targeting market access and commercialization.

Alimentiv Statistics launched the SCoE to provide advisory services related to clinical development strategies, clinical study designs, regulatory authority engagements, and tactical statistical issues that arise in clinical studies. Retaining our broad spectrum of therapeutic area expertise in combination with Alimentiv’s GI-specific statistical strength, the SCoE collaborates with Alimentiv’s Medical Research and Development teams to support Alimentiv customers and sponsors. In addition, a robust team of statisticians and programmers provide flexible, customized, and innovative solutions for clinical trials as well as Real World Evidence and Precision Medicine.

Combining the strengths of Alimentiv’s stats and programming group with the advisory consulting and analysis expertise of McDougall Scientific makes great sense with respect to our service model, which emphasizes leading with science, innovation, and quality delivery.  Alimentiv Statistics creates new potential for our customers to answer important clinical research questions and advance methods.” said Hershell Thompson, Chief Clinical Solutions Officer at Alimentiv.

“ The Alimentiv-McDougall amalgamation has been such a successful marriage of expertise and culture that we are able to launch Alimentiv Statistics sooner than anticipated. New customers, as well as those who have come to rely on McDougall Scientific’s website for informative and educational content, should keep watch on our newly launched site,, where we will continue to post on statistical innovations and relevant statistical content to aid your study planning and execution” said John Amrhein, Vice President, Statistics.

About Alimentiv Inc.

Alimentiv is a global gastroenterology-focused contract research organization (CRO) providing clinical trials, central image management, precision medicine, and real-world evidence services to the pharmaceutical and biotechnology industries. Headquartered in London, Ontario, Alimentiv employs more than 500 people across its operations in Canada, the United States, Europe, Asia-Pacific, and Latin America. The organization’s unique model combines the efforts of internationally recognized academic researchers and operational experts to offer integrated solutions to customers. Over the past 20 years, Alimentiv has become a recognized expert in clinical trial design, central image management solutions, outcome measure development, and precision medicine for drug development in GI. Today, Alimentiv provides services in more than 50 countries worldwide, collaborates with leading universities and academic institutions across the globe, and works with many leading pharmaceutical and biotechnology organizations to bring new and improved treatment options to patients. Alimentiv is committed to investment in medical research and development, focusing on identifying barriers to drug development and pursuing solutions that advance GI research. The research findings are operationalized into an efficient clinical trial methodology for clients that aligns with emerging regulatory standards. In collaboration with leading experts, Alimentiv has pioneered the development, validation, and standardization of outcome measures and technology, shaping the evolving clinical trial landscape for multiple indications and providing meaningful long-term consequences for patients, their treatment, and society. For more information, visit:

Featured Posts